Search

Q&A Pharmacists Have a Role in Health Care System Sustainability As medication experts, pharmacists can advocate for biosimilars and their benefits with organizational decision makers. Fran Gregory, PharmD, MBA, vice [...]

Notable gainers among liquid option names this morning include Waters (WAT) $377.62 +54.51, Charter (CHTR) $377.48 +49.87, Amazon (AMZN) $199.66 +13.26, Agilent (A) $139.06 +8.75, and Cardinal Health (CAH) $115.34 [...]

Eleven years ago, Cardinal Health acquired AssuraMed, a privately held provider of medical supplies to patients in their homes. Cardinal Health at-Home Solutions, the newly created division, allowed Cardinal Health [...]

Notable companies reporting before tomorrow's open, with earnings consensus, include Exxon Mobil (XOM), consensus $1.88... Chevron (CVX), consensus $2.43... Charter Communications (CHTR), consensus $8.67... Cardinal Health (CAH), consensus $1.62... Church [...]

Evercore ISI analyst Elizabeth Anderson is adding Cardinal Health to the firm's 'Tactical Outperform' list ahead of Q3 earnings from the Healthcare Technology and Distribution group. Despite the COVID headwind [...]

T2 Biosystems (TTOO) has entered into a multi-year exclusive U.S. agreement with Cardinal Health (CAH),. Under the agreement, Cardinal Health will have exclusive rights to sell T2 Biosystems' FDA-cleared direct-from-blood [...]

Global Banking News-September 20, 2024-Cardinal Health acquires Integrated Oncology Network (C)2024 ENPublishing - http://www.enpublishing.co.uk Global healthcare services and products company Cardinal Health (NYSE:CAH) announced on Friday that it has agreed [...]

Argus raised the firm's price target on Cardinal Health to $125 from $115 and keeps a Buy rating on the shares after its Q4 results. The company has been facing [...]

Global Banking News-August 22, 2024-PureTech Health appoints new independent director to board (C)2024 ENPublishing - http://www.enpublishing.co.uk PureTech Health plc (Nasdaq:PRTC)(LSE:PRTC) announced on Thursday the appointment of Michele Holcomb, PhD, as [...]

Global Banking News-August 21, 2024-Cardinal Health expands distribution capabilities with New Ohio facility (C)2024 ENPublishing - http://www.enpublishing.co.uk Pharmaceuticals distribution company Cardinal Health (NYSE: CAH) announced on Wednesday that it is [...]

Deutsche Bank analyst George Hill raised the firm's price target on Cardinal Health to $119 from $115 and keeps a Hold rating on the [...]

Evercore ISI removed Cardinal Health from its 'Tactical Outperform' list while keeping an In Line rating on the shares and raising the firm's price target on Cardinal Health to $115 [...]

Morgan Stanley analyst Erin Wright raised the firm's price target on Cardinal Health to $119 from $114 and keeps an Overweight rating on the shares. The firm was 'pleased' by [...]

Baird raised the firm's price target on Cardinal Health to $137 from $130 and keeps an Outperform rating on the shares. The firm said thefFundamental backdrop in core pharma distribution [...]

Wells Fargo analyst Stephen Baxter raised the firm's price target on Cardinal Health to $101 from $95 and keeps an Underweight rating on the shares following quarterly results. The firm [...]

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. [See [...]

Notable gainers among liquid option names this morning include Kellogg (K) $80.00 +5.50, Allstate (ALL) $178.99 +7.03, Progressive (PGR) $230.71 +8.38, Cardinal Health (CAH) $106.31 +3.73, and Morgan Stanley (MS) [...]

Citi lowered the firm's price target on Cardinal Health (CAH) to $107 from $115 and keeps a Neutral rating on the shares. The analyst believes the Q2 reports from the [...]

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on clinical and social pharmacy is the subject of a [...]

Managed Care & Facilities Analyst Gill holds a conference call with CEO Hollar and CFO Alt on June 7 at 10 am. [Webcast [...]

Argus lowered the firm's price target on Cardinal Health to $115 from $120 but keeps a Buy rating on the shares and contends that the recent weakness in the stock [...]

Baird analyst Eric Coldwell lowered the firm's price target on Cardinal Health to $128 from $134 and keeps an Outperform rating on the shares. The firm said they agree with [...]

Morgan Stanley says shares of Cardinal Health should rally on the company's 'solid' fiscal Q3 pharma growth and higher 2025 targets. There was investor scrutiny heading into the print and [...]

Sees FY25 effective tax rate [...]

Consensus $7.28. Sees FY24 effective tax rate 22%-23%. The company said, 'The company raised and narrowed its fiscal year 2024 guidance range for non-GAAP diluted earnings per share attributable to [...]